Epoetin Alfa: a Creative Way to Treat Anemia

Bofan Xu
Additional contact information
Bofan Xu: King’s College London

Journal of Innovations in Medical Research, 2022, vol. 1, issue 2, 28-35

Abstract: The use of epoetin alfa has been one of the most relevant trends in the past years, therefore, it is important to understand how epoetin alfa differs from other biopharmaceuticals and to summarise the innovative nature of epoetin alfa. This paper aims at why the biopharmaceutical represents innovation in terms of lead-discovery, drug development and fulfilling a previously unmet treatment need. As far as we know, studies on the creativity of epoetin alfa are lacking in the main literature. This paper reveals that the purpose of epoetin alfa’s therapy and current treatment modalities, general principles of the drug discovery process, the creativity in medicinal chemistry & pharmacology of epoetin alfa, choosing the target and sources of compound supply, intellectual property considerations in drug discovery & development, the drawbacks of epoetin alfa and the creativity of epoetin alfa. The contribution of the present research involves that summarising the innovation of epoetin alfa.

Keywords: epoetin alfa; anemia; creativity (search for similar items in EconPapers)
Date: 2022
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.paradigmpress.org/jimr/article/view/197/165 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bdz:joimer:v:1:y:2022:i:2:p:28-35

DOI: 10.56397/JIMR/2022.09.04

Access Statistics for this article

More articles in Journal of Innovations in Medical Research from Paradigm Academic Press
Bibliographic data for series maintained by Editorial Office ().